{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T03:09:48Z","timestamp":1789441788983,"version":"build-2803163510"},"reference-count":116,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ymgme.2019.10.011","type":"journal-article","created":{"date-parts":[[2019,11,3]],"date-time":"2019-11-03T01:07:22Z","timestamp":1572743242000},"page":"242-253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Porphyria-induced posterior reversible encephalopathy syndrome and central nervous system dysfunction"],"prefix":"10.1016","volume":"128","author":[{"given":"Daniel A.","family":"Jaramillo-Calle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan M.","family":"Solano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro A.","family":"Rabinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert L.","family":"Bonkovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2019.10.011_bb0005","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S1474-4422(15)00111-8","article-title":"Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions","volume":"14","author":"Fugate","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0010","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJM199602223340803","article-title":"A reversible posterior leukoencephalopathy syndrome","volume":"334","author":"Hinchey","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2019.07.002","article-title":"Acute hepatic porphyrias: current diagnosis & management","author":"Anderson","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2019.03.002","article-title":"Pathogenesis and clinical features of the acute hepatic porphyrias (AHPs)","author":"Bonkovsky","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0025","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.amjmed.2014.10.026","article-title":"Role of delta-aminolevulinic acid in the symptoms of acute porphyria","volume":"128","author":"Bissell","year":"2015","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0030","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/280514a0","article-title":"Delta-Aminolaevulinc acid is a potent agonist for GABA autoreceptors","volume":"280","author":"Brennan","year":"1979","journal-title":"Nature."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0035","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/0014-4886(78)90287-X","article-title":"Neurotoxicity of aminolevulinic acid and porphobilinogen","volume":"62","author":"Pierach","year":"1978","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0040","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-2007-1007139","article-title":"Acute porphyrias: pathogenesis of neurological manifestations","volume":"18","author":"Meyer","year":"1998","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0045","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/bmjebm-2017-110853","article-title":"Methodological quality and synthesis of case series and case reports","volume":"23","author":"Murad","year":"2018","journal-title":"BMJ Evid. Based Med."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0050","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/hep4.1297","article-title":"Acute hepatic porphyrias: review and recent progress","volume":"3","author":"Wang","year":"2018","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0055","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.amjmed.2014.06.036","article-title":"Acute porphyrias in the USA: features of 108 subjects from porphyrias consortium","volume":"127","author":"Bonkovsky","year":"2014","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0060","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/epi.13670","article-title":"Operational classification of seizure types by the international league against epilepsy: position paper of the ILAE commission for classification and terminology","volume":"58","author":"Fisher","year":"2017","journal-title":"Epilepsia."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0065","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-1904","article-title":"Clinical Practice Guideline for screening and management of high blood pressure in children and adolescents","volume":"140","author":"Flynn","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2019.10.011_bb0070","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1097\/HJH.0000000000001961","article-title":"2018 practice guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH\/ESC task force for the management of arterial hypertension","volume":"36","author":"Williams","year":"2018","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0075","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.3174\/ajnr.A0549","article-title":"Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome","volume":"28","author":"Bartynski","year":"2007","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0080","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1681\/ASN.2016101139","article-title":"Diagnosis and treatment of hyponatremia: compilation of the guidelines","volume":"28","author":"Hoorn","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0085","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/01.md.0000152454.56435.f3","article-title":"An analysis of 112 acute porphyric attacks in Cape Town, South Africa","volume":"84","author":"Hift","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ymgme.2019.10.011_bb0090","first-page":"1","article-title":"Acute intermittent porphyria. A clinical and biochemical study of 46 patients","volume":"49","author":"Stein","year":"1970","journal-title":"Medicine(Baltimore)."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0095","first-page":"65","article-title":"Acute hepatic porphyrias in Colombia: an analysis of 101 patients","volume":"44","author":"Jaramillo-Calle","year":"2019","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0100","article-title":"Posterior reversible encephalopathy syndrome in a patient with acute intermittent porphyria","author":"Fourgeaud","year":"2019","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.ymgme.2019.10.011_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.medcli.2019.01.022","article-title":"Reversible encephalopathy syndrome in acute porphyria attack","author":"Losno","year":"2019","journal-title":"Med. Clin. (Barc.)"},{"key":"10.1016\/j.ymgme.2019.10.011_bb0110","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1056\/NEJMcpc0803190","article-title":"Case records of the Massachusetts General Hospital. Case 20-2008: abdominal pain and weakness after gastric bypass surgery","volume":"358","author":"Bonkovsky","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0115","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000330683","article-title":"Neurological complications of acute intermittent porphyria","volume":"66","author":"Kuo","year":"2011","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0120","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.pediatrneurol.2014.05.016","article-title":"Posterior reversible encephalopathy syndrome in acute intermittent porphyria","volume":"51","author":"Zhao","year":"2014","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0125","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/acr.20249","article-title":"A 22-year-old woman with severe headaches, vomiting, and tonic-clonic seizures","volume":"63","author":"Dahlgren","year":"2011","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0130","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s002340050852","article-title":"Acute intermittent porphyria with central pontine myelinolysis and cortical laminar necrosis","volume":"41","author":"Susa","year":"1999","journal-title":"Neuroradiology."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0135","doi-asserted-by":"crossref","first-page":"598","DOI":"10.7326\/0003-4819-123-8-199510150-00006","article-title":"Transient cortical blindness and bioccipital brain lesions in two patients with acute intermittent porphyria","volume":"123","author":"Kupferschmidt","year":"1995","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0140","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1212\/WNL.41.8.1300","article-title":"MRI reveals multiple reversible cerebral lesions in an attack of acute intermittent porphyria","volume":"41","author":"King","year":"1991","journal-title":"Neurology."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0145","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.tjog.2015.08.025","article-title":"Acute intermittent porphyria exacerbation following in vitro fertilization treatment","volume":"55","author":"New","year":"2016","journal-title":"Taiwan. J. Obstet. Gynecol."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0150","first-page":"5","article-title":"Acute intermittent Porphyria","volume":"3","author":"Somana","year":"2017","journal-title":"J. Evol. Res. Med. Biochem."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0155","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00415-009-5415-9","article-title":"Posterior reversible encephalopathy syndrome in a patient with acute intermittent porphyria","volume":"257","author":"Kang","year":"2010","journal-title":"J. Neurol."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0160","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1177\/0004563218774597","article-title":"A case of hereditary coproporphyria with posterior reversible encephalopathy and novel coproporphyrinogen oxidase gene mutation c.863T>G (p.Leu288Trp)","volume":"55","author":"Lambie","year":"2018","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0165","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ebcr.2016.08.004","article-title":"Acute intermittent porphyria presenting with posterior reversible encephalopathy syndrome and lateralized periodic discharges plus fast activity on EEG","volume":"6","author":"Silveira","year":"2016","journal-title":"Epilepsy. Behav. Case Rep."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0170","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000011665","article-title":"Acute intermittent porphyria presenting with seizures and posterior reversible encephalopathy syndrome: two case reports and a literature review","volume":"97","author":"Zheng","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ymgme.2019.10.011_bb0175","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/S0221-0363(09)73594-2","article-title":"Reversible cerebrovascular event during an acute porphyric crisis. A case report","volume":"90","author":"Chateau","year":"2009","journal-title":"J. Radiol."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0180","first-page":"1650","article-title":"Angiographic demonstration of reversible cerebral vasospasm in porphyric encephalopathy","volume":"16","author":"Black","year":"1995","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0185","article-title":"Acute intermittent porphyria with posterior reversible encephalopathy syndrome in pregnancy: a case report","volume":"3","author":"Arora","year":"2019","journal-title":"J. Med. Res. Innov"},{"key":"10.1016\/j.ymgme.2019.10.011_bb0190","doi-asserted-by":"crossref","first-page":"73","DOI":"10.37080\/nmj.20","article-title":"Acute intermittent porphyria- perplexed by the purple","volume":"01","author":"Dutta","year":"2018","journal-title":"Nepal Med J."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0195","article-title":"Acute intermittent porphyria leading to posterior reversible encephalopathy syndrome (PRES): a rare cause of abdominal pain and seizures","volume":"8","author":"Dagens","year":"2016","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.ymgme.2019.10.011_bb0200","doi-asserted-by":"crossref","first-page":"428","DOI":"10.4103\/0972-5229.186262","article-title":"Acute intermittent porphyria: a critical diagnosis for favorable outcome","volume":"20","author":"Divecha","year":"2016","journal-title":"Indian J. Crit. Care Med."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0205","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.neurol.2016.06.002","article-title":"Posterior reversible encephalopathy syndrome revealing acute intermittent porphyria","volume":"172","author":"Gu\u00e9niat","year":"2016","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.ymgme.2019.10.011_bb0210","article-title":"A rare metabolic disorder porphyrias neurological manifestations","volume":"2","author":"Radhakrishnan","year":"2016","journal-title":"Univ. J. Med. Med. Sci."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0215","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/ene.13347","article-title":"Cerebral vasospasm in acute porphyria","volume":"24","author":"Olivier","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0220","series-title":"XXIII Congreso Colombiano de Medicina Interna","first-page":"28","article-title":"Quadriparesis and rhabdomyolysis due to acute intermittent porphyria: Case report","author":"Adams","year":"2014"},{"key":"10.1016\/j.ymgme.2019.10.011_bb0225","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4097\/kjae.2014.67.3.217","article-title":"Severe neurologic manifestations in acute intermittent porphyria developed after spine surgery under general anesthesia: a case report","volume":"67","author":"Park","year":"2014","journal-title":"Korean J Anesth."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0230","doi-asserted-by":"crossref","first-page":"155","DOI":"10.22379\/2422402291","article-title":"Acute intermittent porphyria and its relationship with posterior reversible encephalopathy syndrome: case report","volume":"32","author":"Enr\u00edquez-Marulanda","year":"2016","journal-title":"Acta Neurol\u00f3gica Colomb."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0235","first-page":"454","article-title":"A case of blinding abdominal pain","volume":"101","author":"Mutyaba","year":"2011","journal-title":"S. Afr. Med. J."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0240","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s13312-010-0152-9","article-title":"Acute intermittent porphyria with transient cortical blindness","volume":"47","author":"Bhat","year":"2010","journal-title":"Indian Pediatr."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0245","first-page":"727","article-title":"Cortical blindness in acute intermittent porphyria","volume":"47","author":"Garg","year":"1999","journal-title":"J. Assoc. Physicians India"},{"key":"10.1016\/j.ymgme.2019.10.011_bb0250","first-page":"432","article-title":"Sudden bilateral reversible vision loss: a rare presentation of acute intermittent porphyria","volume":"62","author":"Bhuyan","year":"2014","journal-title":"J. Assoc. Physicians India"},{"key":"10.1016\/j.ymgme.2019.10.011_bb0255","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1017\/S0317167100012221","article-title":"Neuroimaging findings in acute intermittent porphyria","volume":"38","author":"Bicknell","year":"2011","journal-title":"Can J Neurol Sci."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0260","first-page":"177","article-title":"Acute intermittent porphyria presenting as acute pancreatitis and posterior reversible encephalopathy syndrome","volume":"17","author":"Shen","year":"2008","journal-title":"Acta Neurol. Taiwanica"},{"key":"10.1016\/j.ymgme.2019.10.011_bb0265","first-page":"73","article-title":"Posterior reversible leukoencephalopathy (PRES) in acute intermittent porphyria (AIP): a rare neurological complication, Pakistan","volume":"23","author":"Shahid","year":"2016","journal-title":"J. Radiol."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0270","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.nrl.2014.11.003","article-title":"Neuroimaging abnormalities in a patient with posterior reversible encephalopathy syndrome due to acute intermittent porphyria","volume":"31","author":"Rivero Sanz","year":"2016","journal-title":"Neurologia."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0275","doi-asserted-by":"crossref","DOI":"10.1007\/s00115-004-1871-8","article-title":"Cortical amaurosis and status epilepticus with acute porphyria","volume":"76","author":"Wessels","year":"2005","journal-title":"Nervenarzt"},{"key":"10.1016\/j.ymgme.2019.10.011_bb0280","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1259\/bjr\/39757649","article-title":"A severe neurological sequela in acute intermittent porphyria: presentation of a case from encephalopathy to quadriparesis","volume":"81","author":"G\u00fcrses","year":"2008","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0285","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2169\/internalmedicine.56.7654","article-title":"Acute intermittent porphyria presenting with posterior reversible encephalopathy syndrome, accompanied by prolonged vasoconstriction","volume":"56","author":"Takata","year":"2017","journal-title":"Intern. Med."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0290","series-title":"Neurological Manifestations and Molecular Genetics of Acute Intermittent Porphyria in North Western Russia","author":"Pischik","year":"2006"},{"key":"10.1016\/j.ymgme.2019.10.011_bb0295","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1161\/HYPERTENSIONAHA.115.06271","article-title":"Unusual case of severe hypertension in a 20-year-old woman","volume":"66","author":"Pichler","year":"2015","journal-title":"Hypertension."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0300","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bcmd.2016.12.005","article-title":"Reversible MRI findings in a case of acute intermittent porphyria with a novel mutation in the porphobilinogen deaminase gene","volume":"63","author":"Yang","year":"2017","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0305","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jns.2017.03.052","article-title":"Acute intermittent porphyria presenting as posterior reversible encephalopathy syndrome with hyperperfusion in bilateral occipital lobes: a case report","volume":"377","author":"Sakashita","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0310","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/ana.20432","article-title":"Acute intermittent porphyria presenting as a diffuse encephalopathy","volume":"57","author":"Maramattom","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0315","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.brainresbull.2017.03.012","article-title":"Immune system activation in the pathogenesis of posterior reversible encephalopathy syndrome","volume":"131","author":"Chen","year":"2017","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0320","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.biocel.2014.03.032","article-title":"Acute intermittent porphyria causes hepatic mitochondrial energetic failure in a mouse model","volume":"51","author":"Homedan","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0325","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1093\/hmg\/ddv222","article-title":"Mitochondrial energetic defects in muscle and brain of a hmbs\u2212\/\u2212mouse model of acute intermittent porphyria","volume":"24","author":"Homedan","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0330","first-page":"1","article-title":"Chapter 124: disorders of heme biosynthesis: X-linked sideroblastic anemia and the porphyrias","author":"Anderson","year":"2014","journal-title":"Online Metab. Mol. Bases Inherit. Dis."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2019.01.005","article-title":"Sex differences in vascular reactivity in mesenteric arteries from a mouse model of acute intermittent porphyria","author":"Pulgar","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0340","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/jnnp-2017-316225","article-title":"Controversy of posterior reversible encephalopathy syndrome: what have we learnt in the last 20 years?","volume":"89","author":"Gao","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ymgme.2019.10.011_bb0345","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jstrokecerebrovasdis.2011.03.011","article-title":"Blood pressure fluctuations in posterior reversible encephalopathy syndrome","volume":"21","author":"Rabinstein","year":"2012","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0350","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0306-3623(98)00038-X","article-title":"\u03b4-Aminolevulinic acid transport through blood-brain barrier","volume":"31","author":"Garc\u00eda","year":"1998","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0355","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/0014-4886(83)90234-0","article-title":"An autoradiographic study of \u03b4-aminolevulinic acid uptake by mouse brain","volume":"79","author":"Terr","year":"1983","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0360","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1093\/hmg\/ddz003","article-title":"Homozygous hydroxymethylbilane synthase knock-in mice provide pathogenic insights into the severe neurological impairments present in human homozygous dominant acute intermittent porphyria","volume":"28","author":"Yasuda","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0365","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0006-8993(02)03749-6","article-title":"Transport of 5-aminolevulinic acid between blood and brain","volume":"959","author":"Ennis","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0370","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1042\/cs0720103","article-title":"Delta-Aminolevulinic acid in plasma, cerebroespinal fluid, saliva, and erythrocytes: studies in normal, uraemic and porphyrica subjects","volume":"72","author":"Gorchein","year":"1987","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.ymgme.2019.10.011_bb0375","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1073\/pnas.68.11.2725","article-title":"Repression of the overproduction of porphyrin precursors in acute intermittent porphyria by intravenous infusions of hematin","volume":"68","author":"Bonkowsky","year":"1971","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0380","first-page":"219","article-title":"Prophyrin precursors in blood, urine and cerebrospinal fluid in acute porphyria","volume":"52","author":"Percy","year":"1977","journal-title":"S. Afr. Med. J."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0385","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1124\/jpet.104.073098","article-title":"Genetic variants of the human H+\/dipeptide transporter PEPT2: analysis of haplotype functions","volume":"311","author":"Pinsonneault","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0390","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ntt.2014.12.001","article-title":"\u03b4-Aminolevulinic acid dehydratase single nucleotide polymorphism 2 (ALAD2) and peptide transporter 2*2 haplotype (hPEPT2*2) differently influence neurobehavior in low-level lead exposed children","volume":"47","author":"Sobin","year":"2015","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0395","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1681\/ASN.2016080918","article-title":"A variant of peptide transporter 2 predicts the severity of porphyria-associated kidney disease","volume":"28","author":"Tchernitchko","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0400","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4065\/mcp.2009.0590","article-title":"Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings","volume":"85","author":"Fugate","year":"2010","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0405","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/epi.12933","article-title":"Long-term risk of seizures and epilepsy in patients with posterior reversible encephalopathy syndrome","volume":"56","author":"Datar","year":"2015","journal-title":"Epilepsia."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0410","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1111\/j.1471-4159.2007.04905.x","article-title":"Peptide transporter 2 (PEPT2) expression in brain protects against 5-aminolevulinic acid neurotoxicity","volume":"103","author":"Hu","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0415","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1023\/B:PHAM.0000041465.89254.05","article-title":"Role of PEPT2 in the choroid plexus uptake of glycylsarcosine and 5-aminolevulinic acid: studies in wild-type and null mice","volume":"21","author":"Ocheltree","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0420","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/cei.12899","article-title":"Systemic inflammation in acute intermittent porphyria: a case\u2013control study","volume":"187","author":"Storjord","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0425","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF00229595","article-title":"Free radicals involvement in neurological porphyrias and lead poisoning","volume":"103","author":"Monteiro","year":"1991","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0430","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.abb.2004.09.030","article-title":"Mitochondrial and nuclear DNA damage induced by 5-aminolevulinic acid","volume":"432","author":"Onuki","year":"2004","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0435","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1089\/clm.1997.15.83","article-title":"Pilot in vitro toxicity study of 5-ALA and photofrin in microvascular endothelial cell cultures hemangioma","volume":"15","author":"Chang","year":"1997","journal-title":"J. Clin. Laser Med. Surg."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0440","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1600-0412.2011.01238.x","article-title":"Impaired endothelial function and elevated levels of pentraxin 3 in early-onset preeclampsia","volume":"91","author":"Hamad","year":"2012","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063493","article-title":"Elevated circulating levels and tissue expression of pentraxin 3 in uremia: a reflection of endothelial dysfunction","volume":"8","author":"Witasp","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2019.10.011_bb0450","first-page":"354014","article-title":"Pentraxin 3 plasma levels and disease activity in systemic lupus erythematosus","volume":"2015","author":"Assandri","year":"2015","journal-title":"Autoimmune Dis."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0455","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1161\/CIRCULATIONAHA.114.014822","article-title":"Pentraxin 3 induces vascular endothelial dysfunction through a p-selectin\/matrix metalloproteinase-1 pathway","volume":"131","author":"Carrizzo","year":"2015","journal-title":"Circulation."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0460","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/5584_2016_90","article-title":"Endothelial dysfunction and hypertension","volume":"956","author":"Konukoglu","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0465","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/brain\/aws223","article-title":"Acute mitochondrial encephalopathy reflects neuronal energy failure irrespective of which genome the genetic defect affects","volume":"135","author":"Tzoulis","year":"2012","journal-title":"Brain."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0470","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1042\/EBC20170109","article-title":"Neuroimaging in mitochondrial disorders","volume":"62","author":"Mascalchi","year":"2018","journal-title":"Essays Biochem."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0475","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S1474-4422(15)00253-7","article-title":"The diagnosis of posterior reversible encephalopathy syndrome","volume":"14","author":"Ng","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0480","first-page":"93","article-title":"Porphyrin synthesis and mitochondrial respiration in acute intermittent porphyria: studies using cultured human fibroblasts","volume":"85","author":"Bonkowsky","year":"1975","journal-title":"Transl. Res."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0485","article-title":"Feasibility of cellular bioenergetics as a biomarker in porphyria patients","volume":"19","author":"Chacko","year":"2019","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2019.05.010","article-title":"Pilot study of mitochondrial bioenergetics in subjects with acute porphyrias","author":"Dixon","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0495","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fnins.2019.00030","article-title":"Mitochondrial dysfunction in neural injury","volume":"13","author":"Zhao","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0500","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3174\/ajnr.A4214","article-title":"Reversible cerebral vasoconstriction syndrome, part 1: epidemiology, pathogenesis, and clinical course","volume":"36","author":"Miller","year":"2015","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0505","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jphotobiol.2013.06.014","article-title":"Topical hexylaminolevulinate and aminolevulinic acid photodynamic therapy: complete arteriole vasoconstriction occurs frequently and depends on protoporphyrin IX concentration in vessel wall","volume":"126","author":"Middelburg","year":"2013","journal-title":"J. Photochem. Photobiol. B"},{"key":"10.1016\/j.ymgme.2019.10.011_bb0515","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1445-5994.2008.01778.x","article-title":"Nitric oxide and the clinical manifestations of acute porphyria","volume":"38","author":"Thachil","year":"2008","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0520","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/978-1-4939-1441-8_5","article-title":"Nitric oxide availability as a marker of oxidative stress","volume":"1208","author":"Pierini","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0525","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.vph.2016.02.004","article-title":"The role of Na+, K+-ATPase in the hypoxic vasoconstriction in isolated rat basilar artery","volume":"81","author":"Shen","year":"2016","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0530","doi-asserted-by":"crossref","first-page":"F619","DOI":"10.1152\/ajprenal.00502.2007","article-title":"Brain cell volume regulation in hyponatremia: role of sex, age, vasopressin, and hypoxia","volume":"295","author":"Ayus","year":"2008","journal-title":"Am. J. Physiol. Physiol."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0535","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00415-011-6152-4","article-title":"The clinical and radiological spectrum of posterior reversible encephalopathy syndrome: the retrospective Berlin PRES study","volume":"259","author":"Liman","year":"2012","journal-title":"J. Neurol."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0540","doi-asserted-by":"crossref","first-page":"e476","DOI":"10.1097\/MPH.0000000000000827","article-title":"A case of ALL developing posterior reversible encephalopathy secondary to hyponatremia","volume":"39","author":"Eroglu","year":"2017","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0545","doi-asserted-by":"crossref","first-page":"31","DOI":"10.14581\/jer.14008","article-title":"Posterior reversible encephalopathy syndrome due to hyponatremia","volume":"4","author":"Jeon","year":"2014","journal-title":"J. Epilepsy Res."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0550","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-009311","article-title":"Posterior reversible encephalopathy syndrome with documented hyponatraemia","author":"Aulakh","year":"2013","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.ymgme.2019.10.011_bb0555","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/BF00964997","article-title":"Inhibition of Na+, K+-ATPase activity by delta-aminolevulinic acid","volume":"8","author":"Russell","year":"1983","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0560","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/ckj\/sfx146","article-title":"Porphyria and kidney diseases","volume":"11","author":"Pallet","year":"2018","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0565","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000322238","article-title":"Hyponatremia and inflammation: the emerging role of interleukin-6 in osmoregulation","volume":"118","author":"Swart","year":"2011","journal-title":"Nephron Physiol."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0570","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1038\/s41598-018-20947-4","article-title":"The model of circulating immune complexes and interleukin-6 improves the prediction of disease activity in systemic lupus erythematosus","volume":"8","author":"Thanadetsuntorn","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0575","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/cei.13095","article-title":"Differential serum cytokine profile in patients with systemic lupus erythematosus and posterior reversible encephalopathy syndrome","volume":"192","author":"Merayo-Chalico","year":"2018","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0580","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1056\/NEJM197101072840104","article-title":"Blood volume and bilirubin production in acute intermittent porphyria","volume":"284","author":"Bloomer","year":"1971","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2019.10.011_bb0585","doi-asserted-by":"crossref","first-page":"6792","DOI":"10.1007\/s12035-019-1553-y","article-title":"Arginine vasopressin and posterior reversible encephalopathy syndrome pathophysiology: the missing link?","volume":"56","author":"Largeau","year":"2019","journal-title":"Mol. Neurobiol."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719219305840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719219305840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:27:24Z","timestamp":1761089244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719219305840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":116,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1096719219305840"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2019.10.011","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Porphyria-induced posterior reversible encephalopathy syndrome and central nervous system dysfunction","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2019.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}